Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 21, 2008; 14(11): 1720-1733
Published online Mar 21, 2008. doi: 10.3748/wjg.14.1720
Published online Mar 21, 2008. doi: 10.3748/wjg.14.1720
Table 1 Summary of tumor suppressor regulated in HCC
| Symbol | Name | Location | Haploinsufficiency | Downregulation in HCC | Mechanism of regulation | Etiology | |||
| Mutation | Methylation | Chromosome change | Protein overcrossing | ||||||
| p53[312–1421232931–33180] | Tumor protein p53 | 17p13.1 | Yes | Yes | √ | √ | AFB1 | ||
| HBV | |||||||||
| HCV | |||||||||
| Cirrhosis | |||||||||
| p21[51–53] | Cyclin-dependent kinase inhibitor 1A | 6p21.2 | Yes | Yes | p53 | HBV | |||
| HCV | |||||||||
| p27[60] | Cyclin-dependent kinase inhibitor 1B | 12p13.1-12p | Yes | Yes | √ | cirrhosis | |||
| p16[3866–68] | Cyclin-dependent kinase inhibitor 2A | 9p21 | Yes | √ | √ | AFB1 | |||
| p14ARF[38] | Cyclin-dependent kinase inhibitor 2A | 9p21 | Yes | √ | √ | HCV | |||
| Cirrhosis | |||||||||
| E-cadherin[70–73] | E-cadherin | 16q22.1 | Yes | √ | HBV | ||||
| HCV | |||||||||
| Axin 1[74–767879] | Axis inhibitor 1 | 16p13.3 | Yes | √ | √ | HBV | |||
| HCV | |||||||||
| Axin 2[757879] | Axis inhibitor 2 | 17q23-q24 | Yes | √ | √ | ||||
| APC[81–84] | Adenomatosis polyposis coli | 5q21-q22 | Yes | √ | √ | √ | HBV | ||
| HCV | |||||||||
| SOCS1[8990] | Suppressor of cytokine signaling 1 | 16p13.13 | Yes | √ | √ | HCV | |||
| Cirrhosis | |||||||||
| SOCS3[9394] | Suppressor of cytokine signaling 3 | 17q25.3 | Yes | √ | |||||
| RASSF1A[83104105] | Ras association (ralGDS/AF-6) domain family 1 | 3p21.3 | Yes | √ | √ | AFB1 | |||
| HBV | |||||||||
| HCV | |||||||||
| NORE1[94–108] | Ras association (ralGDS/AF-6) domain family 5 | 1q32.1 | Yes | √ | HBV | ||||
| HCV | |||||||||
| Cirrhosis | |||||||||
| KLF6[116119] | Kruppel-like factor 6 | 10p15 | Yes | √ | √ | √ | HBV | ||
| HCV | |||||||||
| Cirrhosis | |||||||||
| PTEN[123127128130] | Phosphatase and tensin homolog | 10q23.3 | Yes | Yes | √ | mTOR | AFB1 | ||
| HBV | |||||||||
| Hint1 | Histidine triad nucleotide binding protein | 5q31.2 | Yes | n.d | n.d | n.d | n.d | n.d | |
| Hint2[144] | Histidine triad nucleotide binding protein 2 | 9p13.3 | Yes | n.d | n.d | n.d | n.d | ||
| FHIT[149–151154157] | Fragile histidine triad gene | 3p14.2 | Yes | Yes | √ | √ | HBV | ||
| HCV | |||||||||
| Cirrhosis | |||||||||
| WWOX[160] | WW domain containing oxidoreductase | 16q23.3-q24 | Yes | √ | AFB1 | ||||
| PARK2[173] | Parkin | 6q25.2-q27 | Yes | ||||||
- Citation: Martin J, Dufour JF. Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1720-1733
- URL: https://www.wjgnet.com/1007-9327/full/v14/i11/1720.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1720
